Attack of the Anthrax 'Virus'

Americans are getting a crash course in microbiology. The delivery of anthrax spores with the daily mail took the U.S. populace completely by surprise. But anyone who has read Ken Alibek's Biohazard, an account of bioweaponry in the former Soviet Union,1 or Richard Preston's fictional The Cobra Event,2 or followed periodic updates on bioterrorism here in The Scientist or in other journals, could have predicted an attempt to subvert biology into weaponry in the wake of Sept. 11. The government k

Written byRicki Lewis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The government knew of the danger too. On Sept. 5, Donald A. Henderson, director of the Center for Civilian Biodefense Studies at Johns Hopkins University, told Congress "biological weapons are a significant threat." But once again, mainstream media are jumping on a life science story as if it sprung from the proverbial ether, much as it did for cloning in 1996 and stem cells in 1998.

While the press and public, not to mention various government officials, struggle to distinguish bacteria from viruses, antibiotics from antibodies, and viruses from vaccines, an underlying message is emerging: As a nation, our science illiteracy has gone from mere embarrassment to a life-threatening problem.

Alas, the U.S postal service's taxonomic designation of anthrax as "poison in the mail" was still the stuff of headlines in early November, conjuring up images of Snow White biting into an apple laced with bacterial spores.

Moving up the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery